ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 224 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q4 2022. The put-call ratio across all filers is 0.80 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $24,222,713 | -3.0% | 679,459 | +25.5% | 1.31% | -2.0% |
| Q2 2023 | $24,978,472 | +1.0% | 541,480 | -12.2% | 1.34% | +28.0% |
| Q1 2023 | $24,720,848 | -34.7% | 616,480 | -24.6% | 1.04% | -34.3% |
| Q4 2022 | $37,859,532 | +928.0% | 817,171 | +818.8% | 1.59% | +939.2% |
| Q3 2022 | $3,683,000 | -82.3% | 88,940 | -74.5% | 0.15% | -80.7% |
| Q2 2022 | $20,793,000 | -45.5% | 348,519 | -33.6% | 0.79% | -32.1% |
| Q1 2022 | $38,133,000 | -6.5% | 525,100 | +8.2% | 1.16% | +47.5% |
| Q4 2021 | $40,804,000 | – | 485,242 | – | 0.79% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 727,426 | $25,932,737 | 4.72% |
| RTW INVESTMENTS, LP | 5,405,089 | $192,691,423 | 4.07% |
| First Light Asset Management, LLC | 1,125,032 | $40,107,391 | 3.81% |
| CHI Advisors LLC | 215,000 | $7,664,750 | 3.04% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 250,052 | $8,914,354 | 3.00% |
| SPHERA FUNDS MANAGEMENT LTD. | 259,135 | $9,238,163 | 1.68% |
| Rock Springs Capital Management LP | 1,476,441 | $52,635,122 | 1.41% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 679,459 | $24,222,713 | 1.31% |
| Privium Fund Management B.V. | 115,241 | $4,108,341 | 1.22% |
| SECTOR GAMMA AS | 115,166 | $4,105,668 | 1.05% |